Westlake Corporation
NYSE:WLKChemicals - Specialty
-$0.85 today
- Market cap
- $7.63B
- Beta
- 0.59
- P/E (TTM)
- -6.5
- EPS (TTM)
- -$12.79
- Dividend yield
- 2.54%
Volume 1.42M
Average 1.10M
WLK Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Westlake CorporationNYSE: WLK
Research & Development · Q3 FY2026 · quarter ended Sep 2026
Research & development remains negative
Q3 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How WLK compares with its peers on the latest reported figures
- WLK's LTM Sep 2026 research & development of $0 is the 8th highest of the 11 companies compared; the peer median is $111.5M.
- Research & development amounts to 0.0% of revenue for WLK, versus a peer median of 1.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $741M | -5.1% | -4.1% | 1.7% | |
| LTM Jun 2026 | $246M | -7.2% | -1.1% | 2.8% | |
| LTM Sep 2026 | $140M | -1.4% | +3.6% | 0.4% | |
| LTM Jun 2026 | $120M | -4.0% | +3.7% | 1.2% | |
| LTM Mar 2026 | $117M | -4.1% | -1.4% | 2.1% | |
| LTM Jun 2026 | $106M | -3.6% | -2.9% | 1.8% | |
| LTM Jun 2026 | $55M | +3.8% | -0.6% | 3.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Aug 2026 | $0 | -100.0% | — | 0.0% | |
| LTM Aug 2026 | $0 | -100.0% | — | 0.0% | |
| LTM Jun 2026 | $0 | -100.0% | — | 0.0% | |
| Peer median (excluding WLK) | $111.5M | -4.6% | -1.1% | 1.5% | |
Competitors are the stored peer set for WLK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 11.78B | 15.79B | 12.55B | 12.14B | 11.17B |
| Cost of Revenue | 8.28B | 11.72B | 10.33B | 10.19B | 10.88B |
| Gross Profit | 3.5B | 4.07B | 2.22B | 1.96B | 289M |
| Gross Margin | 29.7% | 25.8% | 17.7% | 16.1% | 2.6% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 528M | 809M | 865M | 874M | 910M |
| Operating Expenses | 695M | 1.02B | 1.49B | 1.08B | 1.87B |
| Depreciation & Amortization | 840M | 1.06B | 1.1B | 1.11B | 1.18B |
| EBITDA | 3.69B | 4.18B | 1.96B | 2.21B | (258M) |
| EBITDA Margin | 31.4% | 26.5% | 15.6% | 18.2% | -2.3% |
| Operating Income | 2.8B | 3.05B | 729M | 875M | (1.58B) |
| Operating Margin | 23.8% | 19.3% | 5.8% | 7.2% | -14.1% |
| Interest Income | 7M | 24M | 104M | 153M | 0 |
| Interest Expense | 176M | 177M | 165M | 159M | 161M |
| Other Income / Expenses | (123M) | (104M) | (29M) | 63M | (19M) |
| Income Before Tax | 2.68B | 2.95B | 700M | 938M | (1.6B) |
| Pre-Tax Margin | 22.7% | 18.7% | 5.6% | 7.7% | -14.3% |
| Income Tax Expense | 607M | 649M | 178M | 291M | (164M) |
| Net Income | 2.02B | 2.25B | 479M | 602M | (1.51B) |
| Net Margin | 17.1% | 14.2% | 3.8% | 5.0% | -13.5% |
| EPS (Basic) | 15.66 | 17.47 | 3.72 | 4.66 | (11.73) |
| EPS (Diluted) | 15.58 | 17.35 | 3.70 | 4.64 | (11.73) |
| Weighted Avg Shares | 128M | 127.97M | 127.81M | 128.54M | 128.91M |
| Weighted Avg Shares (Diluted) | 128.7M | 128.85M | 128.6M | 129.21M | 128.91M |
Westlake Corporation
NYSE:WLK
Intrinsic Alpha fair value
Locked
Current Price
$59.69
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.